Skip to content
All Updates
- Notification: Directions of Registration Board on Labeling Requirements of Drug Products to Comply Pharmacopeial Specifications for Dissolution TestingFebruary 7, 2023
- DRAP and WHO collaborated to hold a “Two-Day Consultative Meeting on WHO AWaRe Classification of Antimicrobials in the National Essential Medicine List (NEML) of Pakistan”February 2, 2023
- Recall Alert: Drug Product; Awahaem Tablets (Batch # 2781 by M/s. Usawa Pharmaceuticals, Rialpur.January 28, 2023
- Recall Alert: Drug Product; Mefco 50mg/5mL Suspension (Batch # 21053) by M/s Eros Pharmaceuticals, (Pvt) Ltd, Karachi .January 27, 2023
- Recall Alert: Drug Product; Santodex Opthalmic Ointment (Batch # BJ-082) by M/s Sante (Private) Limited, Karachi .January 27, 2023
- Recall Alert: Drug Product; Fenbar 50mg Tablets (Batch # 2752) by M/s Usawa Pharmaceuticals, Risalpur.January 26, 2023
- Decisions of 53rd Meeting of Medical Device Board (Deficiency letters for Imported Medical Devices)January 24, 2023
- Notification: Directions of Registration Board on Reference Product data submissions for conducting Pharmaceutical Equivalence and Comparative Dissolution Profile StudiesJanuary 17, 2023
- Notification: Directions of Registration Board on the Drug Substance (DS) for Product Development, R&D, and Stability TestingJanuary 16, 2023
- SRO 24(I)/2023. Maximum Retail Price (MRP) Fixation of twenty (20) Drugs dated 11th January, 2023January 16, 2023
- Deficiency Letters from EEC 111th and 112th meetingsJanuary 10, 2023
- Minutes of 323rd meeting of Registration Board held from 6th to 8th December, 2022January 9, 2023
- Recall Alert: Drug Product; Paracet 1g/100mL Infusion by M/s Standpharm Pakistan Pvt Ltd, Lahore.January 9, 2023
- Stakeholders Comments are invited on the Draft Guidelines on Good Manufacturing Practices (GMP)January 5, 2023
- Public Awareness: Availability of DrugsJanuary 3, 2023
- DRAP Newsletter: Volume 02-Quarter 01, 2023January 1, 2023
- Testing of Diethylene Glycol (DEG) & Ethylene Glycol (EG) at Central Drug Laboratory, KarachiDecember 30, 2022
- Tender document / terms & conditions for hiring of janitorial services for DRAP head office & NCLB, IslamabadDecember 27, 2022
- Revocation/Cancellation of Form-6 (Provisional Certificate for Enlistment as manufacturer/importer) & Form-7(Provisional Certificate for Enlistment of products)December 27, 2022
- Decisions of 52nd Meeting of Medical Device Board (Deficiency letters Local/Import)December 26, 2022
- Voluntary Recall Alert: Drug Product; Cytotol 200mcg Tablets (Batch # 176,177,178,179,180) by M/s Saffron Pharmaceutical, FaisalabadDecember 22, 2022
- Minutes of 322nd meeting of Registration Board held on 8th & 10th November, 2022December 19, 2022
- Holding of Khuli E-KachehriDecember 13, 2022
- Recall Alert: Drug Product; Tosson 0.4mg SR Capsule by M/s MTI Medical Pvt Ltd, Lahore.December 7, 2022
- Decisions of 51st Meeting of Medical Device Board (Deficiency letters Local/Import)December 5, 2022
- Minutes of 288th Meeting of Central Licensing Board held on 18th October 2022December 2, 2022
- Recall Alert: Drug Product; Ximex 100mg/5mL Suspension by Farmaceutics International KarachiDecember 1, 2022
- Recall Alert: Drug Product; Kempol 120ml/5mL Pediatric Syrup by M/s Alkemy Pharmaceutical Laboratories Pvt Ltd HyderabadDecember 1, 2022
- Rapid Alert: Drug Product; Falsified Restane Inhalational Solution Identified and ConfiscatedDecember 1, 2022
- Rapid Alert: Drug Product; Falsified Tablin 300mg Capsule identified in the marketNovember 30, 2022
- Recall Alert: Drug Product; Ponstan Forte 500mg Tablets (Batch # 2050533) by M/s Pfizer Pakistan Ltd, Karachi.November 30, 2022
- Recall Alert: Drug Product; Diamicron 80mg Tablets (Batch#1740) by M/s. Servier Research & Pharmaceuticals Pakistan (Pvt) Ltd Lahore.November 29, 2022
- Drug Safety Alert: Risk of Kidney Injury and Death due to Hydroxyethyl-Starch Solutions for Infusion.November 29, 2022
- Drug Safety Alert: Increased Risk of Cardiovascular Events with Co-administration and Interaction Between Hydroxychloroquine or Chloroquine, and Macrolide AntibioticsNovember 29, 2022
- Drug Safety Alert: Risk of Major Congenital Malformations with PregabalinNovember 29, 2022
- Rapid Alert: Drug Product; Falsified Xanax 0.5mg Tablets identified in the marketNovember 29, 2022
- DRAP finalized guidelines on Post Registration Variations of Pharmaceutical and Biological Drug ProductsNovember 27, 2022
- Drug Safety Alert: Risk of Reduced Vitamin B12 Level with Metformin and Metformin-Containing MedicinesNovember 25, 2022
- Drug Safety Alert: Risk of Severe Cutaneous Adverse Reactions (SCARs) with AtezolizumabNovember 25, 2022
- Stakeholder Comments are invited on the Draft Therapeutic Goods (Federal Inspectors, Laboratories and Federal Government Analysts) Rules, 2022November 24, 2022
- Drug Safety Update: Risk of Hypothyroidism in Babies and Young Children with Iodinated Contrast Media (ICM) InjectionsNovember 24, 2022
- DRAP invited Comments from Stakeholders on the Draft Therapeutic Goods (Advertisement) Rules, 2022November 22, 2022
- Drug Safety Update; PRAEC issued a Safety Alert on Risk of Sinus Bradycardia with RemdesivirNovember 21, 2022
- Drug Safety Update: Risk of Infusion-Related Hypersensitivity Reactions with RemdesivirNovember 18, 2022
- Drug Safety Alert: Risk of Serious Bowl complications with clozapineNovember 18, 2022
- Drug Safety Alert: Risk of Anaphylactic Reaction / Anaphylactic Shock with Diclofenac Sodium InjectionNovember 18, 2022
- Medicine Safety Week 2022; DRAP’s Call to Healthcare Professionals and Patients to Report Suspected Adverse Reactions of drugs and vaccines.November 14, 2022
- DRAP Signed MoU with Pakistan Single Window to Foster CooperationNovember 12, 2022
- Recall Alert: Drug Product; Moxtrex 400mg Tablets (Batch # 850) by M/s Gillman Pharmaceuticals, Hattar, Khyber PakhtunkhwaNovember 7, 2022
- Recall Alert: Drug Product; Ceficure 400mg Capsules (Batch # C-737) by M/s Max Pharmaceuticals IslamabadNovember 4, 2022